For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220805:nRSE0740Va&default-theme=true
RNS Number : 0740V Impact Healthcare REIT PLC 05 August 2022
5 August 2022
Impact Healthcare REIT plc
("Impact" or the "Company" or, together with its subsidiaries, the "Group")
NOTICE OF HALF YEAR RESULTS
Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust
which gives investors exposure to a diversified portfolio of UK healthcare
real estate assets, in particular care homes, confirms that it will announce
its half year results for the six months ended 30 June 2022 on Tuesday, 16
August 2022.
A Company presentation for analysts and investors will take place on the day
at 8.30am (UK) via a live webcast and conference call.
To access the live webcast, please register in advance here:
https://www.lsegissuerservices.com/spark/ImpactHealthcareREIT/events/59df34ab-a55f-4f99-bc23-963fc7d1ee0b
(https://urldefense.com/v3/__https:/www.lsegissuerservices.com/spark/ImpactHealthcareREIT/events/59df34ab-a55f-4f99-bc23-963fc7d1ee0b__;!!IHJ3XrWN4X8!LwgyMLsI_2R4g7APpfTExU3szO5H8329pJ-qm7ma9OmukuCIIojdWeGv7e93BUl5icmCU5zVN4nZEBPpeI8FK6Zu-z3lzhq-K3tReA$)
To access the live conference call, please register to receive unique dial-in
details here:
https://cossprereg.btci.com/prereg/key.process?key=PTHLAVCCE
(https://urldefense.com/v3/__https:/cossprereg.btci.com/prereg/key.process?key=PTHLAVCCE__;!!IHJ3XrWN4X8!LwgyMLsI_2R4g7APpfTExU3szO5H8329pJ-qm7ma9OmukuCIIojdWeGv7e93BUl5icmCU5zVN4nZEBPpeI8FK6Zu-z3lzhq79OCG0A$)
The recording of the results presentation will be available later in the day
via the Company's London Stock Exchange profile page:
https://www.lsegissuerservices.com/spark/ImpactHealthcareREIT/events/59df34ab-a55f-4f99-bc23-963fc7d1ee0b
(https://urldefense.com/v3/__https:/www.lsegissuerservices.com/spark/ImpactHealthcareREIT/events/59df34ab-a55f-4f99-bc23-963fc7d1ee0b__;!!IHJ3XrWN4X8!LwgyMLsI_2R4g7APpfTExU3szO5H8329pJ-qm7ma9OmukuCIIojdWeGv7e93BUl5icmCU5zVN4nZEBPpeI8FK6Zu-z3lzhq-K3tReA$)
and from the Company website:
https://www.impactreit.uk/investors/reporting-centre/presentations/
(https://www.impactreit.uk/investors/reporting-centre/presentations/)
FOR FURTHER INFORMATION, PLEASE CONTACT:
Impact Health Partners LLP Via Maitland/amo
Andrew Cowley
Mahesh Patel
David Yaldron
Jefferies International Limited +44 20 7029 8000
Tom Yeadon tyeadon@jefferies.com
Neil Winward nwinward@jefferies.com
Ollie Nott onott@jefferies.com
Winterflood Securities Limited +44 20 3100 0000
Neil Langford neil.langford@winterflood.com
Joe Winkley joe.winkley@winterflood.com
Maitland/amo (Communications adviser) +44 7747 113 930
James Benjamin impacthealth-maitland@maitland.co.uk
Alistair de Kare-Silver
The Company's LEI is 213800AX3FHPMJL4IJ53.
Further information on Impact Healthcare REIT is available at
www.impactreit.uk (http://www.impactreit.uk/) .
NOTES:
Impact Healthcare REIT plc acquires, renovates, extends and redevelops high
quality healthcare real estate assets in the UK and lets these assets on
long-term full repairing and insuring leases to high-quality established
healthcare operators which offer good quality care, under leases which provide
the Company with attractive levels of rent cover.
The Company aims to provide shareholders with an attractive sustainable
return, principally in the form of quarterly income distributions and with the
potential for capital and income growth, through exposure to a diversified and
resilient portfolio of UK healthcare real estate assets, in particular care
homes for the elderly.
The Company has a progressive dividend policy with a target to grow its annual
aggregate dividend in line with the inflation-linked rental uplifts received
by the Group under the terms of the rent review provisions contained in the
Group's leases in the prior financial year.
On this basis, the target total dividend for the year ending 31 December 2022
is 6.54 pence per share*, a 2.0% increase over the 6.41 pence in dividends
paid per ordinary share for the year ended 31 December 2021.
The Group's Ordinary Shares were admitted to trading on the main market of the
London Stock Exchange, premium segment, on 8 February 2019. The Company is a
constituent of the FTSE EPRA/NAREIT index.
* This is a target only and not a profit forecast. There can be no
assurance that the target will be met and it should not be taken as an
indicator of the Company's expected or actual results.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NORFIFSDTTIEIIF